SFDA Health Product Advertising: How to Review Healthcare Marketing for Saudi Arabia Compliance

The Saudi Food and Drug Authority (SFDA) regulates the advertising of pharmaceuticals, medical devices, food products, cosmetics, and health supplements in Saudi Arabia with requirements that are among the most restrictive in the region. SFDA's Advertising and Promotion Guidelines establish a pre-approval framework where health product advertising must be reviewed and authorized before publication.

The SFDA has broad enforcement powers, including the authority to recall products, suspend marketing authorizations, impose monetary penalties, and refer cases for criminal prosecution. In a market where health and wellness spending is growing rapidly — driven by Vision 2030's health sector transformation — the volume of health product advertising is increasing, and so is the regulatory scrutiny.

The Regulatory Framework

Key SFDA Advertising Regulations

Regulation	Scope	Key Requirements
Drug Advertising Regulations	Pharmaceuticals	Pre-approval required; prescription drugs cannot be advertised to consumers
Medical Device Advertising	Medical devices	Must match registered indications; pre-approval for consumer advertising
Food Advertising Standards	Food and beverages	Health claims must be substantiated; specific nutritional disclosure requirements
Cosmetics Advertising	Cosmetics and personal care	No medical claims; ingredient disclosure requirements
Health Supplement Advertising	Dietary supplements	Cannot claim to prevent, treat, or cure disease; specific disclaimer requirements
Traditional Medicine	Herbal and traditional products	Must not claim equivalence to registered pharmaceuticals

Pre-Approval Process

The SFDA requires pre-approval for most health product advertising:

Application submission — advertising materials submitted with product registration documentation
Content review — SFDA evaluates claims, disclaimers, and compliance with category-specific regulations
Approval or revision — SFDA approves, requests modifications, or rejects the advertisement
Publication — only approved materials may be published
Post-market surveillance — SFDA monitors published advertising for compliance

Common Health Advertising Compliance Issues

1. Pharmaceutical Advertising

In Saudi Arabia, prescription drug advertising to the general public is prohibited. Only healthcare professional-directed (HCP) advertising is permitted for prescription medications. Common violations include:

Social media posts that describe prescription drug benefits to general audiences
Patient testimonials about prescription medication effectiveness
Disease awareness campaigns that implicitly promote a specific prescription product
Pharmacy window displays that advertise prescription medications

For over-the-counter (OTC) medications, consumer advertising is permitted but restricted:

Claims must match the approved product label
Side effects and contraindications must be included
"Ask your pharmacist" or "Ask your doctor" statements are mandatory
Comparative claims against other medications are prohibited

2. Health Supplement Claims

The health supplement market in Saudi Arabia is rapidly expanding. SFDA regulations strictly limit what supplement advertisements can claim:

Permitted Claims	Prohibited Claims
"Supports immune health"	"Boosts your immune system"
"Contains Vitamin D"	"Cures vitamin D deficiency"
"Part of a healthy lifestyle"	"Prevents disease"
"Dietary supplement"	"Natural medicine" or "alternative to medication"
Specific nutrient content	Therapeutic or medical claims

3. Medical Device Advertising

Medical device advertising must:

Reference only the SFDA-registered indications
Include the device classification and registration number
Not imply capabilities beyond the registered use
Include appropriate safety warnings
Not use testimonials that suggest guaranteed outcomes

4. Food and Beverage Health Claims

SFDA's food advertising standards require:

Health claims must be pre-approved and based on scientific evidence
Nutritional information must follow SFDA's labeling format
"Free from" claims must meet specific thresholds (e.g., "sugar-free" requires less than 0.5g per serving)
Children's food advertising has additional restrictions on health claims and promotional incentives

A Health Advertising Content Review Checklist

Building a Health Content Review Process

Organizations marketing health products in Saudi Arabia should implement:

Regulatory classification: Determine the product category and applicable SFDA regulation
Claim substantiation: Verify that all health claims are supported by evidence acceptable to the SFDA
Internal compliance review: AI-assisted scanning for prohibited claims, missing disclaimers, and registration accuracy
SFDA pre-approval submission: Submit materials with complete supporting documentation
Post-publication monitoring: Audit published content for compliance, including user-generated content and social media

TeamBench enables healthcare and consumer health organizations to build SFDA-specific content reviewers that evaluate health product advertising against Saudi regulatory standards. Custom criteria can check claim permissibility, disclaimer presence, registration accuracy, and Arabic language compliance — catching issues before they reach the SFDA's review desk.

In a market where health product advertising requires pre-approval, the quality of your internal review process directly determines your speed to market and your regulatory risk profile.